Scholarly Index
Jae‐Weon Kim
Seoul National University; 24,604 total citations; 1,009 total publications; best world rank #36
Seoul National University
24,604Total citations
1,009Total publications
78H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Endometrial and Cervical Cancer Treatments | Lifetime | 46 | KR 1 | 99.62 |
| Ovarian cancer diagnosis and treatment | Lifetime | 82 | KR 1 | 99.51 |
| Cervical Cancer and HPV Research | Lifetime | 172 | KR 1 | 99.05 |
| Endometriosis Research and Treatment | Lifetime | 181 | KR 1 | 98.69 |
| Intraperitoneal and Appendiceal Malignancies | Lifetime | 207 | KR 3 | 97.24 |
| Uterine Myomas and Treatments | Lifetime | 354 | KR 7 | 97.61 |
| PARP inhibition in cancer therapy | Lifetime | 321 | KR 3 | 96.10 |
| Ovarian cancer diagnosis and treatment | 2021-2025 | 36 | KR 2 | 99.24 |
| Endometrial and Cervical Cancer Treatments | 2021-2025 | 60 | KR 1 | 98.68 |
| PARP inhibition in cancer therapy | 2021-2025 | 169 | KR 4 | 94.34 |
| Cervical Cancer and HPV Research | 2021-2025 | 401 | KR 6 | 92.60 |
| Endometriosis Research and Treatment | 2021-2025 | 666 | KR 12 | 88.05 |
| Intraperitoneal and Appendiceal Malignancies | 2021-2025 | 323 | KR 11 | 86.02 |
| BRCA gene mutations in cancer | 2021-2025 | 750 | KR 12 | 84.42 |
| Uterine Myomas and Treatments | 2021-2025 | 560 | KR 24 | 85.79 |
| Gestational Trophoblastic Disease Studies | 2021-2025 | 800 | KR 8 | 24.35 |